We found that ACBD3 expression weakly correlated with the infiltration levels of CD4+ T cells (Figure S3), but not with other immune cells, in NSCLC, which argues against the hypothesis that ACBD3-driven secretion modulates TIME. The gene discussed is ACBD3; the disease is non-small cell lung carcinoma.